{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:02:55Z","timestamp":1782514975729,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Innovation Project of Guangxi Graduate Education","award":["YCSW2025248"],"award-info":[{"award-number":["YCSW2025248"]}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["Grant No: 2023GXNSFAA026120"],"award-info":[{"award-number":["Grant No: 2023GXNSFAA026120"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2023GXNSFBA026092"],"award-info":[{"award-number":["2023GXNSFBA026092"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82260608"],"award-info":[{"award-number":["Grant No. 82260608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260554"],"award-info":[{"award-number":["82260554"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Laboratory of Basic Research on Regional Diseases (Guangxi Medical University), Education Department of Guangxi Zhuang Autonomous Region","award":["Grant No. RTFY202302"],"award-info":[{"award-number":["Grant No. RTFY202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11596-025-00150-z","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T06:56:01Z","timestamp":1766386561000},"page":"101-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["OY-TES-1 Splice Variant V5a in Glioma: A Driver of Malignancy and Potential Therapeutic Target"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6836-2396","authenticated-orcid":false,"given":"Wei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qiong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-xia","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-sheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"Suppl 5","key":"150_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019. Neuro Oncol. 2022;24(Suppl 5):v1\u2013v95.","journal-title":"Neuro Oncol."},{"issue":"6","key":"150_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11596-024-2950-7","volume":"44","author":"M Gautam","year":"2024","unstructured":"Gautam M, Gabrani R. Current combinatorial therapeutic aspects: the future prospect for glioblastoma treatment. Curr Med Sci. 2024;44(6):1175\u20131184.","journal-title":"Curr Med Sci."},{"issue":"7","key":"150_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(24)00160-1","volume":"23","author":"A Salvalaggio","year":"2024","unstructured":"Salvalaggio A, Pini L, Bertoldo A, et al. Glioblastoma and brain connectivity: the need for a paradigm shift. Lancet Neurol. 2024;23(7):740\u2013748.","journal-title":"Lancet Neurol."},{"issue":"3","key":"150_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11596-025-00057-9","volume":"45","author":"RC Li","year":"2025","unstructured":"Li RC, Liu C, Wang GJ, et al. ELMOD2 overexpression predicts adverse outcomes and regulates tumor progression in gliomas. Curr Med Sci. 2025;45(3):549\u2013561.","journal-title":"Curr Med Sci."},{"issue":"6","key":"150_CR5","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1073\/pnas.041625098","volume":"98","author":"T Ono","year":"2001","unstructured":"Ono T, Kurashige T, Harada N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer\/testis antigen. Proc Natl Acad Sci U S A. 2001;98(6):3282\u20133287.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"150_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-pharmtox-011112-140326","volume":"54","author":"AW Whitehurst","year":"2014","unstructured":"Whitehurst AW. Cause and consequence of cancer\/testis antigen activation in cancer. Annu Rev Pharmacol Toxicol. 2014;54:251\u2013272.","journal-title":"Annu Rev Pharmacol Toxicol."},{"issue":"7","key":"150_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","volume":"45","author":"A Salmaninejad","year":"2016","unstructured":"Salmaninejad A, Zamani MR, Pourvahedi M, et al. Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest. 2016;45(7):619\u2013640.","journal-title":"Immunol Invest."},{"issue":"6","key":"150_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/ijo.2023.5519","volume":"62","author":"S Ren","year":"2023","unstructured":"Ren S, Zhang Z, Li M, et al. Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review). Int J Oncol. 2023;62(6):71.","journal-title":"Int J Oncol."},{"issue":"3","key":"150_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23(3):135\u2013155.","journal-title":"Nat Rev Cancer."},{"issue":"4","key":"150_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","volume":"24","author":"LE Marasco","year":"2023","unstructured":"Marasco LE, Kornblihtt AR. The physiology of alternative splicing. Nat Rev Mol Cell Biol. 2023;24(4):242\u2013254.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"8","key":"150_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.trecan.2020.04.011","volume":"6","author":"E Wang","year":"2020","unstructured":"Wang E, Aifantis I. RNA splicing and cancer. Trends Cancer. 2020;6(8):631\u2013644.","journal-title":"Trends Cancer."},{"issue":"4","key":"150_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4493","volume":"24","author":"M Seiler","year":"2018","unstructured":"Seiler M, Yoshimi A, Darman R, et al. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers. Nat Med. 2018;24(4):497\u2013504.","journal-title":"Nat Med."},{"issue":"1","key":"150_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-021-00486-7","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qian J, Gu C, et al. Alternative splicing and cancer: a systematic review. Signal Transduct Target Ther. 2021;6(1):78.","journal-title":"Signal Transduct Target Ther."},{"issue":"4","key":"150_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s11596-020-2241-x","volume":"40","author":"B Luo","year":"2020","unstructured":"Luo B, Yun X, Li J, et al. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma. Curr Med Sci. 2020;40(4):719\u2013728.","journal-title":"Curr Med Sci."},{"issue":"5","key":"150_CR15","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.3892\/ol.2017.5799","volume":"13","author":"X Li","year":"2017","unstructured":"Li X, Yan J, Fan R, et al. Serum immunoreactivity of cancer\/testis antigen OY-TES-1 and its tissues expression in glioma. Oncol Lett. 2017;13(5):3080\u20133086.","journal-title":"Oncol Lett."},{"issue":"3","key":"150_CR16","doi-asserted-by":"publisher","first-page":"2293299","DOI":"10.1080\/21645515.2023.2293299","volume":"19","author":"X Zeng","year":"2023","unstructured":"Zeng X, Nong WX, Zou XQ, et al. Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23. Hum Vaccin Immunother. 2023;19(3):2293299.","journal-title":"Hum Vaccin Immunother."},{"issue":"6","key":"150_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1284","volume":"12","author":"L Lin","year":"2024","unstructured":"Lin L, Zou X, Nong W, et al. The potential value of cancer-testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy. Immun Inflamm Dis. 2024;12(6):e1284.","journal-title":"Immun Inflamm Dis."},{"issue":"7","key":"150_CR18","first-page":"7591","volume":"13","author":"YY Ge","year":"2021","unstructured":"Ge YY, Zhang QM, Liu C, et al. Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma. Am J Transl Res. 2021;13(7):7591\u20137609.","journal-title":"Am J Transl Res."},{"key":"150_CR19","doi-asserted-by":"crossref","unstructured":"Bachman J. Reverse-transcription PCR (RT\u2012PCR). In: Laboratory Methods in enzymology: RNA. Amsterdam: Elsevier, 2013:67\u201374.","DOI":"10.1016\/B978-0-12-420037-1.00002-6"},{"issue":"1","key":"150_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/cancers17010146","volume":"17","author":"D Sipos","year":"2025","unstructured":"Sipos D,\u00a0Raposa BL,\u00a0Freihat O, et al. Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes. Cancers (Basel).","journal-title":"Cancers (Basel)."},{"issue":"4","key":"150_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","volume":"18","author":"GBD 2016 Brain and Other CNS Cancer Collaborators","year":"2019","unstructured":"GBD 2016 Brain and Other CNS Cancer Collaborators. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(4):376\u2013393.","journal-title":"Lancet Neurol."},{"issue":"3","key":"150_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11596-022-2593-5","volume":"42","author":"X Wei","year":"2022","unstructured":"Wei X, Zhang QM, Liu C, et al. Microrna-1224-5p is a potential prognostic and therapeutic biomarker in glioblastoma: integrating bioinformatics and clinical analyses. Curr Med Sci. 2022;42(3):584\u2013596.","journal-title":"Curr Med Sci."},{"issue":"5","key":"150_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11596-024-2899-6","volume":"44","author":"HT Lu","year":"2024","unstructured":"Lu HT, Chen YY, Yu YJ, et al. Gene expression profile identifies LncRNA AL355974.3 as a potential glioma biomarker. Curr Med Sci. 2024;44(5):1047\u20131057.","journal-title":"Curr Med Sci."},{"issue":"8","key":"150_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J. Roles and mechanisms of alternative splicing in cancer\u2014implications for care. Nat Rev Clin Oncol. 2020;17(8):457\u2013474.","journal-title":"Nat Rev Clin Oncol."},{"issue":"13","key":"150_CR25","doi-asserted-by":"publisher","first-page":"13684","DOI":"10.18632\/aging.103491","volume":"12","author":"WR Liu","year":"2020","unstructured":"Liu WR, Li CY, Xu WH, et al. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort. Aging. 2020;12(13):13684\u201313700.","journal-title":"Aging."},{"issue":"1","key":"150_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200768","volume":"32","author":"A Naik","year":"2024","unstructured":"Naik A, Lattab B, Qasem H, et al. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer. Mol Ther Oncol. 2024;32(1):200768.","journal-title":"Mol Ther Oncol."},{"issue":"7","key":"150_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins PF, Morgan RA, Feldman SA, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol. 2011;29(7):917\u2013924.","journal-title":"J Clin Oncol."},{"issue":"8","key":"150_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.3910","volume":"21","author":"AP Rapoport","year":"2015","unstructured":"Rapoport AP, Stadtmauer EA, Binder-Scholl GK, et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat Med. 2015;21(8):914\u2013921.","journal-title":"Nat Med."},{"issue":"1","key":"150_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/PL00012077","volume":"6","author":"R Eifuku","year":"2001","unstructured":"Eifuku R, Takenoyama M, Yoshino I, et al. Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes. Int J Clin Oncol. 2001;6(1):34\u201339.","journal-title":"Int J Clin Oncol."},{"issue":"4","key":"150_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1095\/biolreprod.112.107425","volume":"88","author":"Y Kanemori","year":"2013","unstructured":"Kanemori Y, Ryu JH, Sudo M, Niida-Araida Y, Kodaira K, Takenaka M, Kohno N, Sugiura S, Kashiwabara S, Baba T. Two functional forms of ACRBP\/sp32 are produced by pre-mRNA alternative splicing in the mouse. Biol Reprod. 2013;88(4):105.","journal-title":"Biol Reprod."},{"issue":"26","key":"150_CR31","doi-asserted-by":"publisher","first-page":"E3696","DOI":"10.1073\/pnas.1522333113","volume":"113","author":"Y Kanemori","year":"2016","unstructured":"Kanemori Y, Koga Y, Sudo M, et al. Biogenesis of sperm acrosome is regulated by pre-mRNA alternative splicing of Acrbp in the mouse. Proc Natl Acad Sci U S A. 2016;113(26):E3696\u2013E3705.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"150_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41419-019-1668-0","volume":"10","author":"Y Shao","year":"2019","unstructured":"Shao Y, Chong W, Liu X, et al. Alternative splicing-derived intersectin1-L and intersectin1-S exert opposite function in glioma progression. Cell Death Dis. 2019;10(6):431.","journal-title":"Cell Death Dis."},{"issue":"1","key":"150_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-025-02323-0","volume":"11","author":"R Ben Mrid","year":"2025","unstructured":"Ben Mrid R, El Guendouzi S, Mineo M, et al. The emerging roles of aberrant alternative splicing in glioma. Cell Death Discov. 2025;11(1):50.","journal-title":"Cell Death Discov."},{"issue":"8","key":"150_CR34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u20131251.","journal-title":"Neuro Oncol."},{"key":"150_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller M, Wen PY, Chang SM, et al. Glioma. Nat Rev Dis Primers. 2024;10:33.","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"150_CR36","first-page":"1883","volume":"29","author":"D Frappaz","year":"2021","unstructured":"Frappaz D, Bonneville-Levard A, Ricard D, et al. Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias. Support Care Cancer. 2021;29(4):1883\u20131891.","journal-title":"Support Care Cancer."},{"issue":"8","key":"150_CR37","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s00216-010-3821-6","volume":"397","author":"TK Kim","year":"2010","unstructured":"Kim TK, Eberwine JH. Mammalian cell transfection: the present and the future. Anal Bioanal Chem. 2010;397(8):3173\u20133178.","journal-title":"Anal Bioanal Chem."},{"issue":"4","key":"150_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.18388\/abp.2009_2490","volume":"56","author":"K Pluta","year":"2009","unstructured":"Pluta K, Kacprzak MM. Use of HIV as a gene transfer vector. Acta Biochim Pol. 2009;56(4):531\u2013595.","journal-title":"Acta Biochim Pol."},{"issue":"2","key":"150_CR39","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/nar\/gkaa1260","volume":"49","author":"A Fuchs","year":"2021","unstructured":"Fuchs A, Riegler S, Ayatollahi Z, et al. Targeting alternative splicing by RNAi: from the differential impact on splice variants to triggering artificial pre-mRNA splicing. Nucleic Acids Res. 2021;49(2):1133\u20131151.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"150_CR40","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1038\/s41467-025-62066-5","volume":"16","author":"MD Schertzer","year":"2025","unstructured":"Schertzer MD, Stirn A, Isaev K, et al. Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox. Nat Commun. 2025;16(1):6948.","journal-title":"Nat Commun."},{"key":"150_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biocel.2019.06.003","volume":"113","author":"X Zhou","year":"2019","unstructured":"Zhou X, Li X, Yu L, et al. The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma. Int J Biochem Cell Biol. 2019;113:75\u201386.","journal-title":"Int J Biochem Cell Biol."},{"issue":"11","key":"150_CR42","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1093\/brain\/awaa273","volume":"143","author":"AC Fuentes-Fayos","year":"2020","unstructured":"Fuentes-Fayos AC, V\u00e1zquez-Borrego MC, Jim\u00e9nez-Vacas JM, et al. Splicing machinery dysregulation drives glioblastoma development\/aggressiveness: oncogenic role of SRSF3. Brain. 2020;143(11):3273\u20133293.","journal-title":"Brain."},{"key":"150_CR43","doi-asserted-by":"crossref","unstructured":"Bhardwaj S, Sanjay, Yadav AK. Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells. J Neurooncol. 2025;171(1):47\u201363.","DOI":"10.1007\/s11060-024-04831-y"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00150-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:02:51Z","timestamp":1772193771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00150-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00150-z","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they\u00a0have no conflicts of interest\u00a0related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital, Guangxi Medical University (Approval\u00a0No. 2022-KT-\u56fd\u57fa-169). All procedures were\u00a0performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from all individual participants or their legal\u00a0guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets analyzed during this study are available in the TCGA and UCSC Xena repositories. The clinical and splicing data generated in this study are available from the corresponding authors upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data\u00a0and Materials"}}]}}